Frontiers in Pharmacology | Inflammation Pharmacology

Correction

Published on 18 Jan 2023

Corrigendum: A novel N-arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization

in Inflammation Pharmacology

Mingming Fan
Huijuan Xiao
Dingyun Song
Lili Zhu
Jie Zhang
Xinran Zhang
Jing Wang
Huaping Dai
Chen Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1109002

1,628 views

Correction

Published on 18 Jan 2023

Addendum: A novel N-Arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization

in Inflammation Pharmacology

Mingming Fan
Huijuan Xiao
Dingyun Song
Lili Zhu
Jie Zhang
Xinran Zhang
Jing Wang
Huaping Dai
Chen Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1108989

1,743 views
2 citations

Review

Published on 17 Jan 2023

Perturbed autophagy intervenes systemic lupus erythematosus by active ingredients of traditional Chinese medicine

in Inflammation Pharmacology

Rui Tian
Lin Yuan
Yuan Huang
Rui Zhang
Hao Lyu
Shuai Xiao
Dong Guo
Declan William Ali
Marek Michalak
Xing-Zhen Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1053602

6,300 views
5 citations

Original Research

Published on 16 Jan 2023

Association between genetic variants and development of antibodies to infliximab: A cross-sectional study in Chinese patients with Crohn’s disease

in Inflammation Pharmacology

Kouzhu Zhu
Xiaoliang Ding
Zhiyao Chen
Qinhua Xi
Xueqin Pang
Weichang Chen
Liyan Miao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1096816

2,273 views
7 citations

Review

Published on 16 Jan 2023

Targeting type I interferons in systemic lupus erythematous

in Inflammation Pharmacology

Sebastian Bruera
Thandiwe Chavula
Riya Madan
Sandeep K. Agarwal

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1046687

10,462 views
23 citations

Original Research

Published on 13 Jan 2023

Naringenin protects against acute pancreatitis-associated intestinal injury by inhibiting NLRP3 inflammasome activation via AhR signaling

in Inflammation Pharmacology

Xu Yan
Tianjiao Lin
Qingyun Zhu
Yushi Zhang
Zhimin Song
Xinting Pan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1090261

3,921 views
20 citations

Original Research

Published on 13 Jan 2023

Neutralization of excessive CCL28 improves wound healing in diabetic mice

in Inflammation Pharmacology

Zhenlong Chen
Jacob M. Haus
Luisa A. DiPietro
Timothy J. Koh
Richard D. Minshall

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1087924

3,924 views
6 citations

Review

Published on 13 Jan 2023

Ferroptosis as a therapeutic target for inflammation-related intestinal diseases

in Inflammation Pharmacology

Xiaoli Zhang
Yiming Ma
Guoqing Lv
Hongying Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1095366

8,402 views
37 citations

Editorial

Published on 12 Jan 2023

Editorial: Anti-inflammatory immunopharmacology in the prevention and treatment of major chronic diseases

in Inflammation Pharmacology

Qiuwang Zhang
Shihai Yan
Dongdong Sun
Zhirong Geng
Peixiang Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1134918

1,497 views
1 citation

Editorial

Published on 11 Jan 2023

Editorial: Natural compounds regulating epigenetics for treating chronic inflammatory diseases

in Inflammation Pharmacology

Mingyu Zhang
Ok Joo Sul
Junjiang Fu
Qianqian Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1121165

1,552 views

Original Research

Published on 10 Jan 2023

Truncated-semaphorin3A is a potential regulatory molecule to restore immune homeostasis in immune-mediated diseases

in Inflammation Pharmacology

Nasren Eiza
Ofra Kessler
Adi Sabag
Gera Neufeld
E. Yvonne Jones
Zahava Vadasz

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1085892

2,908 views
4 citations

Original Research

Published on 10 Jan 2023

Arbitrary Ca2+ regulation for endothelial nitric oxide, NFAT and NF-κB activities by an optogenetic approach

in Inflammation Pharmacology

Tomoyasu Yamanaka
Takatoshi Ueki
Mitsuhito Mase
Koichi Inoue

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1076116

2,328 views
2 citations

Brief Research Report

Published on 10 Jan 2023

Brief research report: Repurposing pentoxifylline to treat intense acute swimming–Induced delayed-onset muscle soreness in mice: Targeting peripheral and spinal cord nociceptive mechanisms

in Inflammation Pharmacology

Sergio M. Borghi
Tiago H. Zaninelli
Telma Saraiva-Santos
Mariana M. Bertozzi
Renato D. R. Cardoso
Thacyana T. Carvalho
Camila R. Ferraz
Doumit Camilios-Neto
Fernando Q. Cunha
Thiago M. Cunha

Frontiers in Pharmacology

doi 10.3389/fphar.2022.950314

2,421 views
2 citations

Original Research

Published on 09 Jan 2023

Role of M1 macrophages in diabetic foot ulcers and related immune regulatory mechanisms

in Inflammation Pharmacology

Yao Li
Xiaoyan Li
Shuai Ju
Wenqiang Li
Siyuan Zhou
Guili Wang
Yunmin Cai
Zhihui Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1098041

5,328 views
12 citations

Original Research

Published on 06 Jan 2023

Identification of ferroptosis, necroptosis, and pyroptosis-associated genes in periodontitis-affected human periodontal tissue using integrated bioinformatic analysis

in Inflammation Pharmacology

Shuaifei Pan
Yue Li
Haokun He
Shuguang Cheng
Jiang Li
Janak L. Pathak

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1098851

13,057 views
28 citations

Correction

Published on 05 Jan 2023

Corrigendum: Compounds purified from edible fungi fight against chronic inflammation through oxidative stress regulation

in Inflammation Pharmacology

Yidan Xia
Dongxu Wang
Jiaqi Li
Minqi Chen
Duo Wang
Ziping Jiang
Bin Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1081523

1,328 views